0001209191-18-002054.txt : 20180104
0001209191-18-002054.hdr.sgml : 20180104
20180104171111
ACCESSION NUMBER: 0001209191-18-002054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180102
FILED AS OF DATE: 20180104
DATE AS OF CHANGE: 20180104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gulino Richard L.
CENTRAL INDEX KEY: 0001652208
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34186
FILM NUMBER: 18510971
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVENUE
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001347178
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030491827
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
BUSINESS PHONE: 202-734-3400
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-02
0
0001347178
Vanda Pharmaceuticals Inc.
VNDA
0001652208
Gulino Richard L.
2200 PENNSYLVANIA AVENUE
SUITE 300E
WASHINGTON
DC
20037
0
1
0
0
SVP, General Counsel & Sec.
Common Stock
2018-01-02
4
M
0
12500
A
76600
D
Common Stock
2018-01-02
4
M
0
7500
A
99100
D
Common Stock
2018-01-02
4
S
0
10367
15.1987
D
88733
D
Restricted Stock Unit
2018-01-02
4
M
0
12500
0.00
D
Common Stock
12500
25000
D
Restricted Stock Unit
2018-01-02
4
M
0
7500
0.00
D
Common Stock
7500
15000
D
Each Restricted Stock Unit ("RSU") was previously reported on Table II on a Form 4 filed with the Securities and Exchange Commission ("SEC") on September 15, 2015.
Each RSU represents a contingent right to receive a share of the Issuer's Common Stock.
Starting with the January 2, 2018 vesting of the RSUs, the Issuer's method of reporting RSUs has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, the share numbers reported in Column 5 of Table I includes unvested RSUs previously reported in Table II.
Each RSU was previously reported on Table II on a Form 4 filed with the SEC on February 17, 2016.
Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs as reflected in this Form 4. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.15 to $15.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (6) to this Form 4.
The RSUs vest in four (4) equal annual installments beginning January 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
Not Applicable.
/s/ Richard L. Gulino
2018-01-04